Current and future burden of breast cancer: Global statistics for 2020 and 2040

乳腺癌 医学 癌症 肿瘤科 环境卫生 内科学
作者
Melina Arnold,Eileen Morgan,Harriet Rumgay,Allini Mafra da Costa,Deependra Singh,Mathieu Laversanne,Jérôme Vignat,Julie R. Gralow,Fátima Cardoso,Sabine Siesling,Isabelle Soerjomataram
出处
期刊:The Breast [Elsevier]
卷期号:66: 15-23 被引量:1451
标识
DOI:10.1016/j.breast.2022.08.010
摘要

Abstract

Background

Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040.

Methods

Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040.

Results

Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone.

Conclusion

Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研小民工应助kento采纳,获得50
刚刚
完美世界应助小萌采纳,获得10
1秒前
1秒前
gaoww完成签到,获得积分10
1秒前
2秒前
WZ0904发布了新的文献求助10
2秒前
2秒前
lab完成签到 ,获得积分0
2秒前
小蘑菇应助今今采纳,获得10
3秒前
CodeCraft应助秋之月采纳,获得10
3秒前
I1waml完成签到 ,获得积分10
3秒前
3秒前
guygun完成签到,获得积分10
3秒前
zho发布了新的文献求助10
4秒前
独特亦旋发布了新的文献求助10
4秒前
5秒前
研友_LOqqmZ完成签到,获得积分10
6秒前
6秒前
英俊的铭应助文献查找采纳,获得10
6秒前
solobang发布了新的文献求助10
6秒前
Jasper应助老迟到的书雁采纳,获得10
9秒前
orixero应助小二采纳,获得10
9秒前
10秒前
10秒前
simple完成签到,获得积分10
10秒前
caoyy发布了新的文献求助10
10秒前
赵小可可可可完成签到,获得积分10
12秒前
小萌发布了新的文献求助10
13秒前
weiv发布了新的文献求助10
13秒前
海科科发布了新的文献求助10
14秒前
陌上花完成签到,获得积分10
14秒前
我是站长才怪应助微笑襄采纳,获得10
15秒前
caoyy完成签到,获得积分10
16秒前
JamesPei应助独特亦旋采纳,获得10
17秒前
18秒前
18秒前
科目三应助Jenny采纳,获得50
20秒前
gry发布了新的文献求助10
21秒前
Hh发布了新的文献求助10
23秒前
Jzhang应助daniel采纳,获得10
23秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527990
求助须知:如何正确求助?哪些是违规求助? 3108173
关于积分的说明 9287913
捐赠科研通 2805882
什么是DOI,文献DOI怎么找? 1540119
邀请新用户注册赠送积分活动 716941
科研通“疑难数据库(出版商)”最低求助积分说明 709824